Glass slides for mounting brain sections

Quality standard

Glass slides; the source does not report slide dimensions, coating or manufacturer.

Use information

Support immunofluorescence-labeled brain sections for mounting and microscopy.

References

1. protocols.io v2; step protocolsio-2511153; verbatim source: Mount sections onto glass slides

Used in these protocol BOMs

• PSD95 immunofluorescence detection in mouse hippocampal sectionsprotocol #184 · revision 3

  Source version：protocols.io · v2 · Shiyi Wang · This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

  immunohistochemistry

  This reagent's uses & amounts

  • Mounting medium · Support immunofluorescence-labeled brain sections for mounting and microscopy. · Not reported in the source · Glass slides; the source does not report slide dimensions, coating or manufacturer.

  Associated models: 11 protocol→model record(s)1 verified · 0 candidate

  Model → research topic：1 verified · 0 candidate。These statuses apply to individual relationships, not to this reagent.

  Recorded use and applicability limits

  • Protocol → model：Tg2576 transgenic amyloid model (APP695 Swedish)：

    Hippocampal PSD95 immunoreactivity

  • Protocol → model：Tg2576 transgenic amyloid model (APP695 Swedish)：

    Age：Enrolled at 12 months of age, treated continuously for 4 weeks

  • Protocol → model：Tg2576 transgenic amyloid model (APP695 Swedish)：

    Tissue：Fixed free-floating hippocampal brain tissue sections

  • Model → research topic：Tg2576 transgenic amyloid model (APP695 Swedish) → Alzheimer disease：

    Age-dependent memory decline and amyloid plaque study driven by APP Swedish mutation overexpression (Tg2576)

  Show 1 model association(s)

  Tg2576 transgenic amyloid model (APP695 Swedish) · Verified applicability

  This protocol's applicability to this model

  Status：Verified applicability· Evidence type：Literature evidence· Source：https://doi.org/10.1038/cddis.2016.30 ; https://doi.org/10.17504/protocols.io.j8nlk8m4xl5r/v2

  Age：Enrolled at 12 months of age, treated continuously for 4 weeksTissue：Fixed free-floating hippocampal brain tissue sections

  Hippocampal PSD95 immunoreactivity

  Related research topics: 1 (1 verified · 0 candidate)

  • · Alzheimer disease · Verified applicability

    This model's applicability to this disease

    Status：Verified applicability· Evidence type：Literature evidence· Source：PMID:8810256; DOI:10.1126/science.274.5284.99; https://pubmed.ncbi.nlm.nih.gov/8810256/

    Age-dependent memory decline and amyloid plaque study driven by APP Swedish mutation overexpression (Tg2576)

Reference, supply and purchase path

No verified catalog mapping exists for this reagent; reference status: unknown.

No listed sale configuration is published here. This states neither discontinuation nor current stock.